top of page
main-2.png

Designing Genes.

Protecting Lives.

Engineering for Life Protection

Seoul National University’s First Faculty-Led Biotech Spin-off — GeNiner

GeNiner is a biotechnology company developing animal vaccines, human vaccines, and biopharmaceutical materials powered by proprietary gene design technology.

View Products
Technology Inquiry

End-to-End Integration from Recombinant Antigen Design to Production

Gene Design

 13+ Patents & Publications in Biopharmaceuticals

13+ to ‘Patent/Research’

Gene Design

13+ to ‘Patent/Research’

2029 

IPO Target: On Track to Become a Global Biotech Leader

GeNiner Products

main-sub-1.jpg

Animal Vaccine

Customized Vaccines for Poultry and Swine

​

Read More
main-sub-2.jpg

Human Vaccine

Vaccines for Seasonal Influenza and Emerging Viral Threats

Read More
main-sub-3.jpg

Biopharmaceuticals

Development of Antibiotic Alternatives and Novel Biopharmaceutical Materials

Read More
bottom of page